- Home
- TSAT vs AQST Comparison
TSAT vs AQST Comparison
Compare TSAT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- AQST
- Stock Information
- Founded
- TSAT 1969
- AQST 2004
- Country
- TSAT Canada
- AQST United States
- Employees
- TSAT N/A
- AQST N/A
- Industry
- TSAT Metal Fabrications
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- TSAT Industrials
- AQST Health Care
- Exchange
- TSAT Nasdaq
- AQST Nasdaq
- Market Cap
- TSAT 297.9M
- AQST 274.4M
- IPO Year
- TSAT 1996
- AQST 2018
- Fundamental
- Price
- TSAT $25.35
- AQST $2.84
- Analyst Decision
- TSAT Hold
- AQST Strong Buy
- Analyst Count
- TSAT 1
- AQST 7
- Target Price
- TSAT $9.00
- AQST $10.57
- AVG Volume (30 Days)
- TSAT 94.2K
- AQST 1.5M
- Earning Date
- TSAT 05-09-2025
- AQST 03-05-2025
- Dividend Yield
- TSAT N/A
- AQST N/A
- EPS Growth
- TSAT N/A
- AQST N/A
- EPS
- TSAT 2.55
- AQST N/A
- Revenue
- TSAT $450,756,875.00
- AQST $57,561,000.00
- Revenue This Year
- TSAT N/A
- AQST N/A
- Revenue Next Year
- TSAT N/A
- AQST $35.72
- P/E Ratio
- TSAT $9.96
- AQST N/A
- Revenue Growth
- TSAT N/A
- AQST 13.80
- 52 Week Low
- TSAT $6.93
- AQST $2.24
- 52 Week High
- TSAT $25.38
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- TSAT 71.74
- AQST 48.60
- Support Level
- TSAT $20.65
- AQST $2.45
- Resistance Level
- TSAT $23.90
- AQST $3.06
- Average True Range (ATR)
- TSAT 1.91
- AQST 0.22
- MACD
- TSAT 0.63
- AQST 0.02
- Stochastic Oscillator
- TSAT 99.80
- AQST 63.93
About TSAT Telesat Corporation and Class B Variable Voting Shares
Telesat Corp is a global satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.